These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Immune protection, natural products, and skin cancer: is there anything new under the sun? Aboutalebi S, Strickland FM. J Drugs Dermatol; 2006 Jun; 5(6):512-7. PubMed ID: 16774102 [Abstract] [Full Text] [Related]
23. Intravenous ascorbic acid: protocol for its application and use. Riordan HD, Hunninghake RB, Riordan NH, Jackson JJ, Meng X, Taylor P, Casciari JJ, González MJ, Miranda-Massari JR, Mora EM, Rosario N, Rivera A. P R Health Sci J; 2003 Sep; 22(3):287-90. PubMed ID: 14619456 [Abstract] [Full Text] [Related]
24. A cure for miracles. CMAJ; 2001 Feb 06; 164(3):317, 319. PubMed ID: 11232126 [No Abstract] [Full Text] [Related]
25. Immunological aspects of cancer chemotherapy. Zitvogel L, Apetoh L, Ghiringhelli F, Kroemer G. Nat Rev Immunol; 2008 Jan 06; 8(1):59-73. PubMed ID: 18097448 [Abstract] [Full Text] [Related]
26. Preventive effects of vitamin C on carcinogenesis. Lee KW, Lee HJ, Kang KS, Lee CY. Lancet; 2002 Jan 12; 359(9301):172. PubMed ID: 11809299 [No Abstract] [Full Text] [Related]
27. Vitamin C and cancer. Hanck AB. Prog Clin Biol Res; 1988 Jan 12; 259():307-20. PubMed ID: 3283753 [No Abstract] [Full Text] [Related]
28. [Vitamin C and cancer]. Gallmeier WM. MMW Munch Med Wochenschr; 1982 Jan 15; 124(2):31-2. PubMed ID: 6799789 [No Abstract] [Full Text] [Related]
29. [Vitamin C: antioxidant barrier]. Kleszczewska E. Pol Merkur Lekarski; 2001 Jun 15; 10(60):483-6. PubMed ID: 11503271 [Abstract] [Full Text] [Related]
30. Retinol palmitate and ascorbic acid: Role in oncological prevention and therapy. de Carvalho Melo-Cavalcante AA, da Rocha Sousa L, Alencar MVOB, de Oliveira Santos JV, da Mata AMO, Paz MFCJ, de Carvalho RM, Nunes NMF, Islam MT, Mendes AN, Gonçalves JCR, da Silva FCC, Ferreira PMP, de Castro E Sousaa JM. Biomed Pharmacother; 2019 Jan 15; 109():1394-1405. PubMed ID: 30551390 [Abstract] [Full Text] [Related]
32. Enrichment designs: efficiency in development of cancer treatments. Temple RJ. J Clin Oncol; 2005 Aug 01; 23(22):4838-9. PubMed ID: 15983397 [No Abstract] [Full Text] [Related]
33. Intravenous vitamin C as a chemotherapy agent: a report on clinical cases. Riordan HD, Riordan NH, Jackson JA, Casciari JJ, Hunninghake R, González MJ, Mora EM, Miranda-Massari JR, Rosario N, Rivera A. P R Health Sci J; 2004 Jun 01; 23(2):115-8. PubMed ID: 15377059 [Abstract] [Full Text] [Related]
34. Ascorbic acid in the prevention and treatment of cancer. Mata AM, Carvalho RM, Alencar MV, Cavalcante AA, Silva BB. Rev Assoc Med Bras (1992); 2016 Oct 01; 62(7):680-686. PubMed ID: 27925049 [Abstract] [Full Text] [Related]
35. Effect of various natural products on growth of bladder cancer cells: two promising mushroom extracts. Konno S. Altern Med Rev; 2007 Mar 01; 12(1):63-8. PubMed ID: 17397268 [Abstract] [Full Text] [Related]
36. Spectacular reduction in the mortality of acutely injured patients by the administration of vitamins C and E and selenium. Hemilä H. JPEN J Parenter Enteral Nutr; 2009 Mar 01; 33(4):447-8; author reply 449. PubMed ID: 19229041 [No Abstract] [Full Text] [Related]
37. Complementary therapies, herbs, and other OTC agents: vitamin E. Cassileth B. Oncology (Williston Park); 2010 Jun 01; 24(7):661. PubMed ID: 20669806 [No Abstract] [Full Text] [Related]
38. Spicy approach to cancer treatment. Nath S. J Natl Cancer Inst; 2011 Dec 21; 103(24):1817-8. PubMed ID: 22157964 [No Abstract] [Full Text] [Related]
39. Role of marginal vitamin C deficiency in atherogenesis: in vivo models and clinical studies. Frikke-Schmidt H, Lykkesfeldt J. Basic Clin Pharmacol Toxicol; 2009 Jun 21; 104(6):419-33. PubMed ID: 19489786 [Abstract] [Full Text] [Related]